Paradigm Peptides
https://paradigmpeptides.com/ · status: scam-flagged
TRUST SCORE
0
Composite of independent COAs, linked manufacturer certifications,
third-party rankings, and years active. methodology
Profile
| Payments | card, crypto |
|---|---|
| Notes | SCAM-FLAGGED (substantiated criminal conviction). Founders Matthew Kawa and Jennifer Stechkober pled guilty December 10, 2025 in the US District Court for the Northern District of Indiana (US v. Matthew Kawa et al.). Federal investigators determined that many products advertised, labeled, and sold as SARMs in fact contained testosterone (a controlled substance). Additionally, the peptide, hCG, and SARM products were unapproved new drugs under FDCA. Operation shipped from Michigan City, Indiana under the entity Paradigm R.E. LLC. Customer-harm window declared by DOJ: April 2019 – March 2024. paradigmpeptides.com now displays a closure notice; Matthew Kawa's sentencing rescheduled to July 30, 2026. Finnrick's "confident A" rating for Tirzepatide and Retatrutide reflects sample testing through this period and is materially undermined by the later DOJ adulteration findings — listed here as a methodological flag, not a quality endorsement. |
Listings (2)
| Peptide | SKU | Size | Price | Listed purity | In stock |
|---|---|---|---|---|---|
| Retatrutide | — | — | — | — | yes |
| Tirzepatide | — | — | — | — | yes |
Certificates of analysis (2)
| Peptide | Batch | Lab | Method | Measured purity | Date | File |
|---|---|---|---|---|---|---|
| Retatrutide | finnrick-retatrutide | Finnrick Analytics | HPLC (Finnrick independent aggregate) | — | — | PDF → |
| Tirzepatide | finnrick-tirzepatide | Finnrick Analytics | HPLC (Finnrick independent aggregate) | — | — | PDF → |
Third-party rankings
- finnrick.com/products (top-rated rollup) — rank #5 (score: 2) · source